FDA Says Mexican Supplement Now Linked To Death, Stroke

Law360, New York (August 22, 2012, 2:58 PM EDT) -- The U.S. Food and Drug Administration on Tuesday issued a second warning urging consumers to avoid using a pair of “natural” dietary supplements marketed for pain relief, saying that since its first notice the agency has received dozens of additional reports, including instances of death and stroke.

Ongoing FDA lab tests have revealed that Reumofan Plus and Reumofan Plus Premium contain several unlisted and potentially harmful active prescription ingredients that have lead to recent reports of liver injury, severe bleeding, sudden worsening of glucose control, weight...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.